Yang Liu et al. showed that knocking down CXCR7 in GBM cells (U251MG and U373MG) using siRNA to block ERK1/2 in response to CXCL12 decreases cell proliferation, invasion, and migration [93]. The gene discussed is MAPK3; the disease is glioblastoma.